Endotherapy Devices Market Size, Share, Growth, and Industry Analysis, Types (GI Devices & Accessories, ERCP Devices & Accessories, Others), Applications (Hospitals, Clinics, Others), and Regional Insights and Forecast to 2035

Endotherapy Devices Market Size

The Global Endotherapy Devices Market size was USD 8.21 Billion in 2025 and is projected to touch USD 8.60 Billion in 2026, rise to USD 9.00 Billion in 2027, and reach USD 12.99 Billion by 2035, exhibiting a CAGR of 4.69% during the forecast period [2026-2035]. GI procedures contribute nearly 52% of total device usage, while ERCP applications account for about 34%. Hospitals represent close to 58% of overall demand, reflecting procedural concentration in advanced care centers.

The US Endotherapy Devices Market shows consistent growth supported by high screening rates and early adoption of therapeutic endoscopy. Nearly 46% of GI procedures involve endotherapy devices. Outpatient settings contribute around 31% of usage, while hospitals account for approximately 59%. Single-use accessories influence close to 28% of purchasing decisions, supporting steady market expansion.

Key Findings

• Market Size: Valued at USD 8.21 Billion in 2025, projected to touch $8.60Bn in 2026 to $12.99Bn by 2035 at a CAGR of 4.69%.
• Growth Drivers: Minimally invasive procedures 64%, GI disorders 41%, outpatient care 31%.
• Trends: Single-use tools 31%, ergonomic designs 22%, outpatient expansion 27%.
• Key Players: Olympus, Boston Scientific, Medtronic, Fujifilm, Karl Storz.
• Regional Insights: North America 41%, Europe 29%, Asia-Pacific 22%, Middle East & Africa 8%.
• Challenges: Specialist dependency 33%, device complexity 28%.
• Industry Impact: Procedure efficiency improvement 27%, complication reduction 18%.
• Recent Developments: Single-use adoption 31%, ergonomic upgrades 22%.

A unique aspect of the endotherapy devices market is its reliance on procedural expertise rather than volume alone. Nearly 34% of purchasing decisions are influenced by clinician familiarity and workflow compatibility, making training and device ergonomics as important as technical performance.

Endotherapy Devices Market Trends

The Endotherapy Devices Market is shaped by steady growth in minimally invasive gastrointestinal procedures and broader adoption of endoscopic interventions across care settings. Around 64% of therapeutic GI procedures are now performed using endotherapy techniques, reducing the need for open surgery. Hospitals account for nearly 58% of total endotherapy device usage, while clinics contribute about 29% as outpatient procedures increase. GI devices and accessories represent close to 52% of procedural volume due to their routine use in diagnosis and treatment. ERCP-related procedures contribute roughly 31% of demand, driven by biliary and pancreatic disorder management. Reusable devices still make up about 61% of usage, although single-use accessories are gaining traction at nearly 39% to reduce infection risks. Procedure efficiency has improved by approximately 27% with newer device designs, while complication rates have declined by nearly 18%. Physician preference for precision tools influences close to 34% of purchasing decisions. Overall, market trends reflect a clear shift toward safer, faster, and more targeted therapeutic interventions.

Endotherapy Devices Market Dynamics

OPPORTUNITY

"Growth in minimally invasive GI treatments"

Minimally invasive GI treatments continue to expand as clinicians prioritize reduced recovery times and lower complication risks. Nearly 47% of GI interventions now favor endotherapy over surgical alternatives. Patient preference for shorter hospital stays influences about 36% of procedure selection. Advanced accessories improve procedural accuracy by roughly 22%, creating opportunities for specialized device adoption in complex interventions.

DRIVERS

"Rising prevalence of GI and biliary disorders"

Gastrointestinal and biliary disorders remain a key driver for endotherapy devices. Nearly 41% of therapeutic endoscopic procedures address biliary complications. Pancreatic disorders contribute close to 19% of ERCP device usage. Early intervention through endotherapy reduces surgical escalation by about 24%, reinforcing clinical reliance on these devices.

RESTRAINTS

"High dependency on skilled specialists"

Endotherapy procedures require specialized training and experience. Around 33% of healthcare facilities report limited access to trained endoscopists. Procedural variability affects outcomes in nearly 21% of cases, restricting broader adoption in smaller centers and slowing penetration outside urban hospitals.

CHALLENGE

"Device handling complexity and standardization gaps"

Complex device handling remains a challenge for consistent outcomes. Nearly 28% of clinicians cite workflow integration issues. Variation in device compatibility affects about 17% of procedures, while sterilization and reprocessing concerns influence roughly 23% of purchasing decisions.

Segmentation Analysis

The Global Endotherapy Devices Market size was USD 8.21 Billion in 2025 and is projected to touch USD 8.60 Billion in 2026, rise to USD 9.00 Billion in 2027, and reach USD 12.99 Billion by 2035, exhibiting a CAGR of 4.69% during the forecast period [2026-2035]. Segmentation analysis highlights how device type and care setting influence adoption, utilization frequency, and purchasing priorities across the market.

By Type

GI Devices & Accessories

GI devices and accessories are the most widely used endotherapy tools, supporting routine diagnostic and therapeutic procedures. They account for nearly 52% of total demand due to frequent use in polypectomy, hemostasis, and tissue resection. Improved maneuverability enhances procedural success rates by approximately 26%.

GI Devices & Accessories accounted for USD 4.47 Billion in 2026, representing around 52% of the market, and are expected to grow at a CAGR of 4.69% from 2026 to 2035 driven by high procedure volumes.

ERCP Devices & Accessories

ERCP devices are essential for managing biliary and pancreatic conditions. This segment represents about 34% of market usage. Advanced guidewires and stents improve access efficiency by nearly 21%, supporting complex therapeutic interventions.

ERCP Devices & Accessories reached USD 2.92 Billion in 2026, accounting for roughly 34% share, and are projected to grow at a CAGR of 4.69% from 2026 to 2035 due to rising biliary disorder treatments.

Others

Other endotherapy devices include specialized tools for niche procedures. This segment contributes close to 14% of demand and supports advanced therapeutic customization in select clinical cases.

Other endotherapy devices accounted for USD 1.21 Billion in 2026, representing approximately 14% share, and are expected to grow at a CAGR of 4.69% from 2026 to 2035.

By Application

Hospitals

Hospitals dominate endotherapy device usage due to access to advanced infrastructure and skilled specialists. This segment accounts for nearly 58% of total demand. High procedural throughput supports consistent device utilization.

Hospitals accounted for USD 4.99 Billion in 2026, representing about 58% share, and are expected to grow at a CAGR of 4.69% from 2026 to 2035.

Clinics

Clinics are expanding their role in outpatient endotherapy procedures. They contribute around 29% of market usage, supported by faster recovery protocols and reduced inpatient dependency.

Clinics reached USD 2.49 Billion in 2026, capturing roughly 29% share, and are projected to grow at a CAGR of 4.69% from 2026 to 2035.

Others

Other applications include ambulatory surgical centers and specialty units. These account for nearly 13% of device usage, focusing on targeted therapeutic procedures.

Other applications accounted for USD 1.12 Billion in 2026, representing approximately 13% share, and are expected to grow at a CAGR of 4.69% from 2026 to 2035.

Endotherapy Devices Market Regional Outlook

The Global Endotherapy Devices Market size was USD 8.21 Billion in 2025 and is projected to touch USD 8.60 Billion in 2026, increase further to USD 9.00 Billion in 2027, and reach USD 12.99 Billion by 2035, exhibiting a CAGR of 4.69% during the forecast period [2026-2035]. Regional performance varies based on access to endoscopy infrastructure, specialist availability, procedure volumes, and healthcare investment levels. North America, Europe, Asia-Pacific, and Middle East & Africa together account for 100% of market demand, with different adoption stages and procedural maturity shaping regional trends.

North America

North America remains the largest regional market for endotherapy devices due to high procedural volumes and strong adoption of minimally invasive GI interventions. Nearly 49% of therapeutic endoscopic procedures use advanced endotherapy devices. Hospitals account for about 61% of device utilization, while outpatient centers contribute close to 27%. ERCP-related procedures represent nearly 35% of regional demand, reflecting high biliary disorder treatment rates.

North America held approximately 41% of the global Endotherapy Devices Market in 2026, accounting for USD 3.53 Billion, supported by advanced clinical infrastructure and strong physician preference for endoscopic therapies.

Europe

Europe shows stable demand supported by standardized clinical pathways and aging populations. GI endotherapy procedures account for nearly 54% of device usage in the region. Clinics and ambulatory centers contribute around 32% of total procedures, reflecting strong outpatient adoption. Reusable endotherapy devices remain dominant, representing close to 63% of use.

Europe represented about 29% of the market in 2026, valued at USD 2.49 Billion, driven by high diagnostic screening rates and consistent therapeutic intervention volumes.

Asia-Pacific

Asia-Pacific is expanding steadily as healthcare access improves and endoscopic procedures increase. Urban hospitals account for nearly 57% of regional demand, while clinics contribute around 25%. GI disorders represent close to 48% of endotherapy procedures, with ERCP adoption rising gradually. Training programs influence nearly 21% of purchasing decisions.

Asia-Pacific accounted for approximately 22% market share in 2026, equivalent to USD 1.89 Billion, supported by rising procedure volumes and hospital expansion.

Middle East & Africa

The Middle East & Africa region shows gradual adoption with demand concentrated in tertiary hospitals. Hospitals represent nearly 66% of device usage, while clinics account for about 19%. Imported devices dominate supply, contributing close to 59% of availability. Trauma and emergency GI procedures support steady utilization.

Middle East & Africa held around 8% of the market in 2026, amounting to USD 0.69 Billion, supported by growing hospital investments and specialist care expansion.

List of Key Endotherapy Devices Market Companies Profiled

Investment Analysis and Opportunities in Endotherapy Devices Market

Investment in endotherapy devices continues to focus on procedural efficiency, device integration, and outpatient expansion. Nearly 44% of investments target advanced GI devices and accessories used in high-volume procedures. Training and physician education initiatives receive close to 19% of investment attention to improve adoption consistency. Outpatient and clinic-based endotherapy expansion accounts for around 27% of capital allocation. Single-use accessories attract approximately 23% of investment due to infection control priorities. Emerging markets represent nearly 21% of expansion-focused investments as endoscopic capacity grows. Partnerships between device manufacturers and hospitals influence around 18% of investment strategies, supporting long-term procedural growth.

New Products Development

New product development in the endotherapy devices market emphasizes precision, usability, and procedural safety. Slimmer device profiles improve navigation efficiency by nearly 24%. Enhanced torque control features reduce procedural time by about 19%. Single-use endotherapy accessories now represent close to 31% of new launches, addressing sterilization concerns. Integrated visualization compatibility appears in around 37% of new products. Ergonomic handle designs reduce operator fatigue by nearly 22%. These innovations focus on improving clinical outcomes while supporting workflow efficiency across hospitals and clinics.

Recent Developments

• Advanced GI Accessories: New accessory designs improved procedural accuracy by nearly 21% across therapeutic interventions.
• Single-Use ERCP Tools: Disposable devices increased infection control compliance by around 18%.
• Improved Device Ergonomics: Redesigned handles reduced clinician fatigue by approximately 22%.
• Outpatient-Focused Systems: Compact systems increased clinic adoption by nearly 17%.
• Training-Supported Devices: Integrated guidance features reduced handling errors by about 20%.

Report Coverage

This report provides comprehensive coverage of the Endotherapy Devices Market, examining device types, applications, and regional adoption trends. It covers GI devices, ERCP accessories, and other therapeutic tools accounting for nearly 100% of endotherapy procedures. Application analysis includes hospitals, clinics, and other care settings representing the full usage spectrum. Regional coverage spans North America, Europe, Asia-Pacific, and Middle East & Africa, together accounting for total market demand. The report evaluates procedural trends where minimally invasive GI therapies represent over 60% of interventions. Competitive analysis profiles manufacturers accounting for more than 70% of device supply. Product development trends influencing nearly 55% of new launches are reviewed. The study also assesses training needs, workflow challenges, and standardization gaps affecting adoption. Overall, the report delivers structured insights into market dynamics, technology evolution, and strategic opportunities.